{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T09:39:29Z","timestamp":1786527569884,"version":"build-2736575974"},"reference-count":301,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006742","name":"Cooperativa de Ensino Superior Polit\u00e9cnico e Universit\u00e1rio","doi-asserted-by":"publisher","award":["TargetMito-GI2-CESPU-2025"],"award-info":[{"award-number":["TargetMito-GI2-CESPU-2025"]}],"id":[{"id":"10.13039\/501100006742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006742","name":"Cooperativa de Ensino Superior Polit\u00e9cnico e Universit\u00e1rio","doi-asserted-by":"publisher","award":["RECAP-DCA-GI2-CESPU-2025"],"award-info":[{"award-number":["RECAP-DCA-GI2-CESPU-2025"]}],"id":[{"id":"10.13039\/501100006742","id-type":"DOI","asserted-by":"publisher"}]},{"award":["TargetMito-GI2-CESPU-2025"],"award-info":[{"award-number":["TargetMito-GI2-CESPU-2025"]}],"id":[{"id":"https:\/\/ror.org\/00w7bj245","id-type":"ROR","asserted-by":"publisher"}]},{"award":["RECAP-DCA-GI2-CESPU-2025"],"award-info":[{"award-number":["RECAP-DCA-GI2-CESPU-2025"]}],"id":[{"id":"https:\/\/ror.org\/00w7bj245","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Oral cancer, predominantly represented by oral squamous cell carcinoma (OSCC), remains a major global health burden due to its aggressive clinical behavior, high recurrence rates, and limited improvement in survival over recent decades. Despite advances in treatment modalities, patient outcomes remain poor largely due to late diagnosis, therapeutic resistance, and profound tumor heterogeneity. In particular, metabolic reprogramming has emerged as a central hallmark of oral carcinogenesis, enabling tumor cells to adapt to hypoxic and nutrient-deprived microenvironments while promoting proliferation, invasion, and treatment resistance. Traditional experimental models, including two-dimensional cell cultures and in vivo animal models, have provided important mechanistic insights. However, they fail to fully recapitulate the metabolic, structural, and cellular complexity of human tumors. Consequently, there is growing interest in more physiologically relevant platforms, such as three-dimensional spheroids, organoids, and patient-derived models, which better preserve tumor architecture and microenvironmental interactions. In parallel, multi-omics approaches are increasingly being integrated to dissect the molecular and metabolic complexity of oral cancer at unprecedented resolutions, while nanotechnology-based systems are emerging as promising tools for targeted drug delivery and improved therapeutic precision. This review discusses experimental models in oral cancer research, focusing on their ability to capture metabolic alterations and tumor heterogeneity. We further highlight their translational potential together with multi-omics integration and nanotechnology-based strategies for improving biomarker discovery, therapeutic stratification, and the development of more effective treatment approaches.<\/jats:p>","DOI":"10.3390\/pharmaceutics18080995","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T09:11:36Z","timestamp":1786525896000},"page":"995","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Experimental Models and Nanotechnology-Based Platforms in Oral Squamous Cell Carcinoma: From Tumor Biology to Translational Applications"],"prefix":"10.3390","volume":"18","author":[{"given":"Patricia Rodr\u00edguez","family":"Carballido","sequence":"first","affiliation":[{"name":"UNIPRO\u2014Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS)-CESPU, 4585-116 Gandra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4455-4286","authenticated-orcid":false,"given":"Jo\u00e3o P. N.","family":"Silva","sequence":"additional","affiliation":[{"name":"UNIPRO\u2014Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS)-CESPU, 4585-116 Gandra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3012-1079","authenticated-orcid":false,"given":"Andrea","family":"Cunha","sequence":"additional","affiliation":[{"name":"UNIPRO\u2014Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS)-CESPU, 4585-116 Gandra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0694-7321","authenticated-orcid":false,"given":"Patr\u00edcia M. A.","family":"Silva","sequence":"additional","affiliation":[{"name":"UNIPRO\u2014Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS)-CESPU, 4585-116 Gandra, Portugal"},{"name":"Associate Laboratory i4HB, Institute for Health and Bioeconomy, University Institute of Health Sciences (IUCS)-CESPU, 4585-116 Gandra, Portugal"},{"name":"UCIBIO\u2014Applied Molecular Biosciences Unit, Translational Toxicology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS)-CESPU, 4585-116 Gandra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Rumgay, H., Colombet, M., Ramos da Cunha, A., Filho, A.M., Warnakulasuriya, S., Conway, D.I., Chaturvedi, A., Virani, S., Lauby-Secretan, B., and Carvalho, A.L. (2026). Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022. CA Cancer J. Clin., 76.","DOI":"10.3322\/caac.70048"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2016016272","article-title":"Oral Squamous Cell Carcinoma: Current Treatment Strategies and Nanotechnology-Based Approaches for Prevention and Therapy","volume":"33","author":"Gharat","year":"2016","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The Emerging Hallmarks of Cancer Metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","article-title":"Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer","volume":"171","author":"Puram","year":"2017","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Pinto, B., Henriques, A.C., Silva, P.M.A., and Bousbaa, H. (2020). Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12121186"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1039\/D3LC00531C","article-title":"Bridging the gap between tumor-on-chip and clinics: A systematic review of 15 years of studies","volume":"23","author":"Bouquerel","year":"2023","journal-title":"Lab Chip"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"103045","DOI":"10.1016\/j.copbio.2023.103045","article-title":"Progress and challenges in the translation of cancer nanomedicines","volume":"85","author":"Tong","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_11","first-page":"e82552","article-title":"The Demographic and Clinical Characteristics of Oral Squamous Cell Carcinoma: An Institutional Epidemiological Study","volume":"17","author":"M","year":"2025","journal-title":"Cureus"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Barsouk, A.A., Aluru, J.S., Rawla, P., Saginala, K., and Barsouk, A.A. (2023). Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma. Med. Sci., 11.","DOI":"10.3390\/medsci11020042"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.oraloncology.2008.06.002","article-title":"Global epidemiology of oral and oropharyngeal cancer","volume":"45","author":"Warnakulasuriya","year":"2009","journal-title":"Oral Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1758-3284-3-11","article-title":"The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neck","volume":"3","author":"Chau","year":"2011","journal-title":"Head Neck Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1007\/s00784-019-02958-1","article-title":"The synergistic effect of tobacco and alcohol consumption on oral squamous cell carcinoma: A systematic review and meta-analysis","volume":"23","author":"Mello","year":"2019","journal-title":"Clin. Oral Investig."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Aswathi, G., Carvalho, A., Palaniraja, S., Shivacharan, M., Naik, B.N.K., Warnakulasuriya, S., Chaudhry, K., Kulkarni, M., Shetty, R.S., and Lewis, S. (2026). Evaluation of dose-response relationships between smoking tobacco, alcohol consumption and oral cancer: A systematic review and meta-analysis. BMC Public Health, 26.","DOI":"10.1186\/s12889-026-27796-1"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.semcancer.2021.11.002","article-title":"The oral microbiota and its role in carcinogenesis","volume":"86","author":"Stasiewicz","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1186\/s12967-025-07189-5","article-title":"Impact of oral anaerobic bacteria on the tumor immune microenvironment and prognosis of oral cancer","volume":"23","author":"Kashima","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.6004\/jnccn.2025.0007","article-title":"NCCN Guidelines\u00ae Insights: Head and Neck Cancers, Version 2.2025","volume":"23","author":"Colevas","year":"2025","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"(2021). Department of Error. Lancet, 397, 2252.","DOI":"10.1016\/S0140-6736(21)01217-4"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.critrevonc.2019.03.001","article-title":"Breast cancer risk of hormonal contraception: Counselling considering new evidence","volume":"137","author":"Peccatori","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.identj.2024.04.005","article-title":"Prognostic Analysis of Lactic Acid Metabolism Genes in Oral Squamous Cell Carcinoma","volume":"74","author":"Shen","year":"2024","journal-title":"Int. Dent. J."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Mostafa, R.G., Hashim, M.I., Bawahab, A.A., Baloush, R.A.A., Abdelwahed, M.S., Hasan, A., Ismail, K.A., Abd-Elhameed, N.R., Embaby, A., and Sharfeldeen, A.E.R.M. (2025). Immunohistochemical Expression of Glucose Transporter-1 in Oral Epithelial Dysplasia and Different Grades of Oral Squamous Cell Carcinoma. Medicina, 61.","DOI":"10.3390\/medicina61040557"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"33745","DOI":"10.18632\/oncotarget.25850","article-title":"Nuclear PKM2 promotes the progression of oral squamous cell carcinoma by inducing EMT and post-translationally repressing TGIF2","volume":"9","author":"Tanaka","year":"2018","journal-title":"Oncotarget"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12935-023-03110-6","article-title":"Comparative clinical significance and biological roles of PFKFB family members in oral squamous cell carcinoma","volume":"23","author":"Hu","year":"2023","journal-title":"Cancer Cell Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Cai, H., Li, J., Zhang, Y., Liao, Y., Zhu, Y., Wang, C., and Hou, J. (2019). LDHA Promotes Oral Squamous Cell Carcinoma Progression Through Facilitating Glycolysis and Epithelial\u2013Mesenchymal Transition. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.01446"},{"key":"ref_32","first-page":"189","article-title":"GLUT1 Expression in Oral Squamous Cell Carcinoma and Its Significance","volume":"15","author":"Haneef","year":"2024","journal-title":"Middle East J. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1002\/mco2.218","article-title":"Metabolic reprogramming in cancer: Mechanisms and therapeutics","volume":"4","author":"Nong","year":"2023","journal-title":"MedComm"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3390\/molecules15042374","article-title":"Glut1 and Glut3 as Potential Prognostic Markers for Oral Squamous Cell Carcinoma","volume":"15","author":"Ayala","year":"2010","journal-title":"Molecules"},{"key":"ref_35","first-page":"2529","article-title":"Monocarboxylate transporter 1 is an independent prognostic factor in esophageal squamous cell carcinoma","volume":"41","author":"Chen","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4103\/jomfp.JOMFP_334_19","article-title":"Epithelial\u2013mesenchymal transition in oral squamous cell carcinoma: An insight into molecular mechanisms and clinical implications","volume":"24","author":"Jayanthi","year":"2020","journal-title":"J. Oral Maxillofac. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/ijc.33352","article-title":"Epithelial-to-mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities","volume":"148","author":"Ling","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.2147\/OTT.S251518","article-title":"lncRNA MALAT1 Promotes EMT Process and Cisplatin Resistance of Oral Squamous Cell Carcinoma via PI3K\/AKT\/m-TOR Signal Pathway","volume":"13","author":"Wang","year":"2020","journal-title":"Onco. Targets. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12935-022-02676-x","article-title":"Role of PI3K\/AKT pathway in squamous cell carcinoma with an especial focus on head and neck cancers","volume":"22","author":"Abak","year":"2022","journal-title":"Cancer Cell Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12943-024-02193-7","article-title":"Metabolic targeting of regulatory T cells in oral squamous cell carcinoma: New horizons in immunotherapy","volume":"23","author":"Gan","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Network (2015). Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature, 517, 576\u2013582.","DOI":"10.1038\/nature14129"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e18108","DOI":"10.1111\/jcmm.18108","article-title":"Unravelling the heterogeneity of oral squamous cell carcinoma by integrative analysis of single-cell and bulk transcriptome data","volume":"28","author":"Li","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.cell.2020.08.043","article-title":"Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma","volume":"182","author":"Ji","year":"2020","journal-title":"Cell"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Ahmed, S.P., Castresana, J.S., and Shahi, M.H. (2021). Glioblastoma and MiRNAs. Cancers, 13.","DOI":"10.3390\/cancers13071581"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1158\/1078-0432.CCR-10-1408","article-title":"Hypoxia Inducible Factor 1\u03b1 and Hypoxia Inducible Factor 2\u03b1 Play Distinct and Functionally Overlapping Roles in Oral Squamous Cell Carcinoma","volume":"16","author":"Zhu","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10565-025-10048-0","article-title":"Oral squamous cell carcinoma: Insights into cellular heterogeneity, drug resistance, and evolutionary trajectories","volume":"41","author":"Zhou","year":"2025","journal-title":"Cell Biol. Toxicol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/s42003-023-05510-w","article-title":"Flavinated SDHA underlies the change in intrinsic optical properties of oral cancers","volume":"6","author":"Marumo","year":"2023","journal-title":"Commun. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s41199-020-00056-4","article-title":"Preclinical models of head and neck squamous cell carcinoma for a basic understanding of cancer biology and its translation into efficient therapies","volume":"5","author":"Tinhofer","year":"2020","journal-title":"Cancers Head Neck"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1158\/0008-5472.CAN-04-3953","article-title":"A Cell Proliferation Signature Is a Marker of Extremely Poor Outcome in a Subpopulation of Breast Cancer Patients","volume":"65","author":"Dai","year":"2005","journal-title":"Cancer Res."},{"key":"ref_51","first-page":"1657","article-title":"Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas","volume":"41","author":"Rheinwald","year":"1981","journal-title":"Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3353\/omp.9.133","article-title":"Establishment and Characterization of Human Oral Squamous Cell Carcinoma Cell Lines","volume":"9","author":"Fujisawa","year":"2004","journal-title":"Oral Med. Pathol."},{"key":"ref_53","first-page":"20","article-title":"Establishment and characterization of a cell line (SAS) from poorly differentiated human squamous cell carcinoma of the tongue","volume":"38","author":"Takahashi","year":"1989","journal-title":"J. Jpn. Stomatol. Soc."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0277-5379(88)90335-5","article-title":"Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: Establishment, characterization and response to cytotoxic treatment","volume":"24","author":"Gioanni","year":"1988","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41568-018-0057-9","article-title":"Publisher Correction: The molecular landscape of head and neck cancer","volume":"18","author":"Leemans","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1177\/10454411010120060401","article-title":"Adhesive Mechanisms Regulating Invasion and Metastasis in Oral Cancer","volume":"12","author":"Ziober","year":"2001","journal-title":"Crit. Rev. Oral Biol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41419-026-08664-7","article-title":"HOXA9 orchestrates EMT and metastasis in oral cancer via transcriptional activation of vimentin and \u03b2-catenin signaling","volume":"17","author":"Shenoy","year":"2026","journal-title":"Cell Death Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e1977","DOI":"10.1002\/hsr2.1977","article-title":"Genes involved in metastasis in oral squamous cell carcinoma: A systematic review","volume":"7","author":"Mohtasham","year":"2024","journal-title":"Health Sci. Rep."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"de Morais, E.F., de Oliveira, L.Q.R., Marques, C.E., T\u00e9o, F.H., Rocha, G.V., Rodini, C.O., Gurgel, C.A., Salo, T., Graner, E., and Coletta, R.D. (2025). Generation and Characterization of Cisplatin-Resistant Oral Squamous Cell Carcinoma Cells Displaying an Epithelial\u2013Mesenchymal Transition Signature. Cells, 14.","DOI":"10.3390\/cells14171311"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Guerra-Librero, A., Fernandez-Gil, B.I., Florido, J., Martinez-Ruiz, L., Rodr\u00edguez-Santana, C., Shen, Y.-Q., Garc\u00eda-Verdugo, J.M., L\u00f3pez-Rodr\u00edguez, A., Rusanova, I., and Qui\u00f1ones-Hinojosa, A. (2021). Melatonin Targets Metabolism in Head and Neck Cancer Cells by Regulating Mitochondrial Structure and Function. Antioxidants, 10.","DOI":"10.3390\/antiox10040603"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Botha, H., Farah, C.S., Koo, K., Cirillo, N., McCullough, M., Paolini, R., and Celentano, A. (2021). The Role of Glucose Transporters in Oral Squamous Cell Carcinoma. Biomolecules, 11.","DOI":"10.3390\/biom11081070"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Jiang, W., Zhang, T., Zhang, H., Han, T., Ji, P., and Ou, Z. (2023). Metabolic Patterns of High-Invasive and Low-Invasive Oral Squamous Cell Carcinoma Cells Using Quantitative Metabolomics and 13C-Glucose Tracing. Biomolecules, 13.","DOI":"10.3390\/biom13121806"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s41199-018-0030-z","article-title":"Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC)","volume":"3","author":"Jung","year":"2018","journal-title":"Cancers Head Neck"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.oraloncology.2018.05.018","article-title":"Metabolic signature of squamous cell carcinoma of the head and neck: Consequences of TP53 mutation and therapeutic perspectives","volume":"83","author":"Wilkie","year":"2018","journal-title":"Oral Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e157285","DOI":"10.1172\/jci.insight.157285","article-title":"Macrophage secretory IL-1\u03b2 promotes docetaxel resistance in head and neck squamous carcinoma via SOD2\/CAT-ICAM1 signaling","volume":"7","author":"Hsieh","year":"2022","journal-title":"JCI Insight"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"BSR20202083","DOI":"10.1042\/BSR20202083","article-title":"Suppression of oral cancer by induction of cell cycle arrest and apoptosis using Juniperus communis extract","volume":"40","author":"Lee","year":"2020","journal-title":"Biosci. Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/s12967-023-04343-9","article-title":"IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR\/JNK\/SOX2 pathway","volume":"21","author":"Yuan","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Zhao, H., Park, Y.M., Zheng, Y., Mao, Q., Collet, C., Hu, B., Zhou, T., Lin, L., Wong, S., and Pan, Y. (2025). Genetically Defined Organoid Models Reveal Mechanisms Driving Squamous Cell Neoplastic Evolution and Identify Potential Therapeutic Vulnerabilities. bioRxiv, bioRxiv:2025.01.18.631624.","DOI":"10.1101\/2025.01.18.631624"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/adt.2014.573","article-title":"Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors","volume":"12","author":"Edmondson","year":"2014","journal-title":"Assay Drug Dev. Technol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Chen, F., Ning, K., Xie, Y., Yang, X., Yu, L., and Wang, X. (2026). Three-Dimensional Tumor Spheroids Reveal B7-H3 CAR T Cell Infiltration Dynamics and Microenvironment-Induced Functional Reprogramming in Solid Tumors. Cells, 15.","DOI":"10.3390\/cells15020169"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Chitturi Suryaprakash, R.T., Kujan, O., Shearston, K., and Farah, C.S. (2020). Three-Dimensional Cell Culture Models to Investigate Oral Carcinogenesis: A Scoping Review. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249520"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"100622","DOI":"10.1016\/j.oor.2024.100622","article-title":"Revolutionizing precision medicine in oral squamous cell carcinoma: Harnessing 3D in vitro models for translation","volume":"11","author":"Buldak","year":"2024","journal-title":"Oral Oncol. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/biot.200900004","article-title":"Characterization of cell viability during bioprinting processes","volume":"4","author":"Nair","year":"2009","journal-title":"Biotechnol. J."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Miyamoto, S., Nishikiori, N., Sato, T., Watanabe, M., Umetsu, A., Tsugeno, Y., Hikage, F., Sasaya, T., Kato, H., and Ogi, K. (2023). Three-Dimensional Spheroid Configurations and Cellular Metabolic Properties of Oral Squamous Carcinomas Are Possible Pharmacological and Pathological Indicators. Cancers, 15.","DOI":"10.3390\/cancers15102793"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymben.2022.07.008","article-title":"13C metabolic flux analysis clarifies distinct metabolic phenotypes of cancer cell spheroid mimicking tumor hypoxia","volume":"73","author":"Noguchi","year":"2022","journal-title":"Metab. Eng."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12967-018-1407-9","article-title":"Correction to: Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma","volume":"16","author":"Eckert","year":"2018","journal-title":"J. Transl. Med."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Eckert, A.W., Kappler, M., Gro\u00dfe, I., Wickenhauser, C., and Seliger, B. (2020). Current Understanding of the HIF-1-Dependent Metabolism in Oral Squamous Cell Carcinoma. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176083"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mbs.2014.09.007","article-title":"Modeling the dynamics of hypoxia inducible factor-1\u03b1 (HIF-1\u03b1) within single cells and 3D cell culture systems","volume":"258","author":"Leedale","year":"2014","journal-title":"Math. Biosci."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Miao, Y., Wang, P., Huang, J., Qi, X., Liang, Y., Zhao, W., Wang, H., Lyu, J., and Zhu, H. (2024). Metabolomics, Transcriptome and Single-Cell RNA Sequencing Analysis of the Metabolic Heterogeneity between Oral Cancer Stem Cells and Differentiated Cancer Cells. Cancers, 16.","DOI":"10.3390\/cancers16020237"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Nayak, P., Bentivoglio, V., Varani, M., and Signore, A. (2023). Three-Dimensional In Vitro Tumor Spheroid Models for Evaluation of Anticancer Therapy: Recent Updates. Cancers, 15.","DOI":"10.3390\/cancers15194846"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.medj.2023.04.003","article-title":"Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification","volume":"4","author":"Millen","year":"2023","journal-title":"Med"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1002\/hsr2.580","article-title":"Head and neck cancer organoids as a promising tool for personalized cancer therapy: A literature review","volume":"5","author":"Mohtasham","year":"2022","journal-title":"Health Sci. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/0194599818756627","article-title":"Assessing the Impact of Targeting CEACAM1 in Head and Neck Squamous Cell Carcinoma","volume":"159","author":"Tam","year":"2018","journal-title":"Otolaryngol. Neck Surg."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1158\/2159-8290.CD-20-0129","article-title":"Correction: Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy","volume":"10","author":"Zandvliet","year":"2020","journal-title":"Cancer Discov."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11596-019-2050-2","article-title":"Lactate Promotes Cancer Stem-like Property of Oral Sequamous Cell Carcinoma","volume":"39","author":"Zhao","year":"2019","journal-title":"Curr. Med. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13578-022-00785-8","article-title":"Histone methyltransferase KMT2D cooperates with MEF2A to promote the stem-like properties of oral squamous cell carcinoma","volume":"12","author":"Wang","year":"2022","journal-title":"Cell Biosci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/0022034520956614","article-title":"3D Co-culture of Cancer-Associated Fibroblast with Oral Cancer Organoids","volume":"100","author":"Zhao","year":"2021","journal-title":"J. Dent. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","article-title":"Organoid Modeling of the Tumor Immune Microenvironment","volume":"175","author":"Neal","year":"2018","journal-title":"Cell"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","article-title":"Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids","volume":"174","author":"Dijkstra","year":"2018","journal-title":"Cell"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41568-018-0104-6","article-title":"Modelling cancer in microfluidic human organs-on-chips","volume":"19","author":"Hassell","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"189627","DOI":"10.1016\/j.bbcan.2026.189627","article-title":"A comprehensive review of microfluidic-based organ-on-chip technology in the application of preclinical drug discovery studies","volume":"1881","author":"Shetty","year":"2026","journal-title":"Biochim. Biophys. Acta-Rev. Cancer"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1126\/science.1188302","article-title":"Reconstituting Organ-Level Lung Functions on a Chip","volume":"328","author":"Huh","year":"2010","journal-title":"Science"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"102801","DOI":"10.1016\/j.mtbio.2026.102801","article-title":"Emerging roles of microfluidics in oral cancer research and clinical translation","volume":"37","author":"Li","year":"2026","journal-title":"Mater. Today Bio"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1186\/s12967-025-06824-5","article-title":"Innovative organ-on-a-chip platforms for exploring tumorigenesis and therapy in head and neck cancer","volume":"23","author":"Lin","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Demers, I., Donkers, J., Kremer, B., and Speel, E.J. (2020). Ex Vivo Culture Models to Indicate Therapy Response in Head and Neck Squamous Cell Carcinoma. Cells, 9.","DOI":"10.3390\/cells9112527"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"439","DOI":"10.12688\/f1000research.131810.2","article-title":"Development of an in vitro microfluidic model to study the role of microenvironmental cells in oral cancer metastasis","volume":"12","author":"Scemama","year":"2024","journal-title":"F1000Research"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1039\/D5LC00572H","article-title":"Dual-channel six-step linear concentration gradient microfluidic chip for orthogonal combination drug screening in head and neck tumor cells","volume":"25","author":"Liao","year":"2025","journal-title":"Lab Chip"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10544-025-00748-z","article-title":"A 3D vascularized tumor spheroid microfluidic platform for head and neck cancer research: New insights","volume":"27","author":"Bang","year":"2025","journal-title":"Biomed. MicroDevices"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nbt.2989","article-title":"Microfluidic organs-on-chips","volume":"32","author":"Bhatia","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling Development and Disease with Organoids","volume":"165","author":"Clevers","year":"2016","journal-title":"Cell"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41578-018-0034-7","article-title":"Advances in organ-on-a-chip engineering","volume":"3","author":"Zhang","year":"2018","journal-title":"Nat. Rev. Mater."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41573-020-0079-3","article-title":"Organs-on-chips: Into the next decade","volume":"20","author":"Low","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"021502","DOI":"10.1063\/5.0186722","article-title":"Engineering models of head and neck and oral cancers on-a-chip","volume":"18","author":"Vignolo","year":"2024","journal-title":"Biomicrofluidics"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41563-021-01057-5","article-title":"Next-generation cancer organoids","volume":"21","author":"LeSavage","year":"2022","journal-title":"Nat. Mater."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Engelmann, L., Thierauf, J., Koerich Laureano, N., Stark, H.-J., Prigge, E.-S., Horn, D., Freier, K., Grabe, N., Rong, C., and Federspil, P. (2020). Organotypic Co-Cultures as a Novel 3D Model for Head and Neck Squamous Cell Carcinoma. Cancers, 12.","DOI":"10.3390\/cancers12082330"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Naipal, K.A.T., Verkaik, N.S., S\u00e1nchez, H., van Deurzen, C.H.M., den Bakker, M.A., Hoeijmakers, J.H.J., Kanaar, R., Vreeswijk, M.P.G., Jager, A., and van Gent, D.C. (2016). Tumor slice culture system to assess drug response of primary breast cancer. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2119-2"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/bjc.2013.700","article-title":"Slice cultures from head and neck squamous cell carcinoma: A novel test system for drug susceptibility and mechanisms of resistance","volume":"110","author":"Gerlach","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Capala, M.E., Pachler, K.S., Lauwers, I., de Korte, M.A., Verkaik, N.S., Mast, H., Jonker, B.P., Sewnaik, A., Hardillo, J.A., and Keereweer, S. (2023). Ex Vivo Functional Assay for Evaluating Treatment Response in Tumor Tissue of Head and Neck Squamous Cell Carcinoma. Cancers, 15.","DOI":"10.3390\/cancers15020478"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Meijer, T.G., Naipal, K.A., Jager, A., and van Gent, D.C. (2017). Ex Vivo Tumor Culture Systems for Functional Drug Testing and Therapy Response Prediction. Futur. Sci. OA, 3.","DOI":"10.4155\/fsoa-2017-0003"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"17187","DOI":"10.1038\/srep17187","article-title":"Capturing complex tumour biology in vitro: Histological and molecular characterisation of precision cut slices","volume":"5","author":"Davies","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/s41591-021-01398-3","article-title":"An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer","volume":"27","author":"Voabil","year":"2021","journal-title":"Nat. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.biotechadv.2016.11.002","article-title":"3D tumor spheroids: An overview on the tools and techniques used for their analysis","volume":"34","author":"Costa","year":"2016","journal-title":"Biotechnol. Adv."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Kondo, J., and Inoue, M. (2019). Application of Cancer Organoid Model for Drug Screening and Personalized Therapy. Cells, 8.","DOI":"10.3390\/cells8050470"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Li, Q., Dong, H., Yang, G., Song, Y., Mou, Y., and Ni, Y. (2020). Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00212"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1038\/s41467-022-32738-7","article-title":"In vivo tumor immune microenvironment phenotypes correlate with inflammation and vasculature to predict immunotherapy response","volume":"13","author":"Sahu","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/ame2.70066","article-title":"Establishment of a patient-derived drug-resistant oral squamous cell carcinoma animal model","volume":"8","author":"Feng","year":"2025","journal-title":"Anim. Model. Exp. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1158\/2159-8290.CD-15-0012","article-title":"Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage\u2013Derived VEGFA","volume":"5","author":"Harney","year":"2015","journal-title":"Cancer Discov."},{"key":"ref_119","first-page":"627","article-title":"Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis","volume":"16","author":"Wu","year":"2024","journal-title":"Aging"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1038\/s41598-023-32568-7","article-title":"Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft","volume":"13","author":"Dozmorov","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41583-020-0326-y","article-title":"Author Correction: Reproducibility of animal research in light of biological variation","volume":"21","author":"Voelkl","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1288\/00005537-198501000-00012","article-title":"An in vivo model for squamous cell carcinoma of the head and neck","volume":"95","author":"Baker","year":"1985","journal-title":"Laryngoscope"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e37523","DOI":"10.1016\/j.heliyon.2024.e37523","article-title":"Chlorogenic acid exhibits antitumor effect in patient-derived xenograft models and hydrogel-embedded tissue culture drug susceptibility test of tongue cancer","volume":"10","author":"Zhu","year":"2024","journal-title":"Heliyon"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13046-017-0553-x","article-title":"The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma","volume":"36","author":"Feng","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1744806916666841","DOI":"10.1177\/1744806916666841","article-title":"BDNF signaling contributes to oral cancer pain in a preclinical orthotopic rodent model","volume":"12","author":"Chodroff","year":"2016","journal-title":"Mol. Pain."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"3135470","DOI":"10.1155\/2022\/3135470","article-title":"Establishment and Identification of Patient-Derived Xenograft Model for Oral Squamous Cell Carcinoma","volume":"2022","author":"He","year":"2022","journal-title":"J. Oncol."},{"key":"ref_127","first-page":"e91625","article-title":"Comparison of the Anticancer Effects of a Complementary Peptide for Dickkopf WNT Signaling Pathway Inhibitor 3 (DKK3) With Conventional Anticancer Drugs in the Treatment of Oral Squamous Cell Carcinoma: A Pilot Study","volume":"17","author":"Katase","year":"2025","journal-title":"Cureus"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3892\/etm.2013.938","article-title":"An animal model of buccal mucosa cancer and cervical lymph node metastasis induced by U14 squamous cell carcinoma cells","volume":"5","author":"Zhao","year":"2013","journal-title":"Exp. Ther. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1158\/2767-9764.CRC-25-0008","article-title":"Impact of Subcutaneous Versus Orthotopic Implantations on Patient-Derived Xenograft Transcriptomic Profiles","volume":"5","author":"Sheng","year":"2025","journal-title":"Cancer Res. Commun."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Yen, W.-C., Chang, I.Y.-F., Chang, K., Ouyang, C., Liu, C.-R., Tsai, T.-L., Zhang, Y.-C., Wang, C.-I., Wang, Y.-H., and Yu, A.L. (2022). Genomic and Molecular Signatures of Successful Patient-Derived Xenografts for Oral Cavity Squamous Cell Carcinoma. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.792297"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"103949","DOI":"10.1016\/j.identj.2025.103949","article-title":"Glycolytic Reprogramming in Oral Squamous Cell Carcinoma: Molecular Regulators and Natural Product-Based Therapies","volume":"75","author":"Shin","year":"2025","journal-title":"Int. Dent. J."},{"key":"ref_132","first-page":"55","article-title":"2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma Cells","volume":"24","author":"Sobhakumari","year":"2016","journal-title":"Oncol. Res. Featur. Preclin. Clin. Cancer Ther."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40170-021-00275-4","article-title":"Dynamic regulation of mitochondrial pyruvate metabolism is necessary for orthotopic pancreatic tumor growth","volume":"9","author":"Mohan","year":"2021","journal-title":"Cancer Metab."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/cac2.12273","article-title":"Aberrant translation regulated by METTL1\/WDR4-mediated tRNA N7-methylguanosine modification drives head and neck squamous cell carcinoma progression","volume":"42","author":"Chen","year":"2022","journal-title":"Cancer Commun."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Cunha, A., Rocha, A.C., Barbosa, F., Bai\u00e3o, A., Silva, P., Sarmento, B., and Queir\u00f3s, O. (2022). Glycolytic Inhibitors Potentiated the Activity of Paclitaxel and Their Nanoencapsulation Increased Their Delivery in a Lung Cancer Model. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14102021"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1038\/s41598-019-41523-4","article-title":"Targeting cellular metabolism to reduce head and neck cancer growth","volume":"9","author":"Yang","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1080\/15384047.2020.1720485","article-title":"Doxycycline-induced exogenous Bmi-1 expression enhances tumor formation in a murine model of oral squamous cell carcinoma","volume":"21","author":"Kalish","year":"2020","journal-title":"Cancer Biol. Ther."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Barbosa, F., Cunha, A., Barbosa, J., Faria, J., and Queir\u00f3s, O. (2025). The Dual Role of Metformin: Repurposing an Antidiabetic Drug for Cancer Therapy. Appl. Sci., 15.","DOI":"10.3390\/app152111576"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"eadq7305","DOI":"10.1126\/sciadv.adq7305","article-title":"Identifying metabolic limitations in the tumor microenvironment","volume":"10","author":"Cognet","year":"2024","journal-title":"Sci. Adv."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Schneeberger, V.E., Allaj, V., Gardner, E.E., Poirier, J.T., and Rudin, C.M. (2016). Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0160587"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"De La Rochere, P., Loumagne, L., Rathaux, M., Dubois, M., Denizeau, J., Nemati, F., Viel, S., Rocha, D., Slavnic, T., and Thatte, J. (2026). A comprehensive analysis of humanized mouse models for the study of cancer immunotherapies. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1730378"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e1246","DOI":"10.1002\/cti2.1246","article-title":"Preclinical evaluation of cancer immune therapy using patient-derived tumor antigen-specific T cells in a novel xenograft platform","volume":"10","author":"Shenoy","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/vms3.1161","article-title":"Exploring animal models in oral cancer research and clinical intervention: A critical review","volume":"9","author":"Khayatan","year":"2023","journal-title":"Vet. Med. Sci."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Chakraborty, A.K., Choudhury, C., Raut, R.D., and Bais, M.V. (2025). A Humanized Mouse Model of Oral Squamous Cell Carcinoma for Investigating Resistance to Anti-PD1 Immunotherapy. bioRxiv, bioRxiv:2025.06.13.659630.","DOI":"10.1101\/2025.06.13.659630"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Nowak, A., Marlow, R., Ryan, K., Lapointe, J.-M., Sutton, D., Sharpe, A., Crook, L., Walker, J.A., Little, E., and Peverill, J. (2025). A comprehensive welfare scoring system for graft versus host disease clinical assessment in humanised mouse models used for pharmaceutical research. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1617528"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Liu, X., Wang, D., Cheng, X., Ma, Y., Li, S., Deng, J., and Qiao, C. (2026). Fibroblast\u2013immune crosstalk in oral squamous cell carcinoma: From tumor promotion to immune evasion. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1703277"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Qin, X., Wu, H., Pan, J., Kang, K., Shi, Y., and Bu, S. (2025). Immune-metabolic crosstalk in HNSCC: Mechanisms and therapeutic opportunities. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1553284"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/2767-9764.CRC-23-0386","article-title":"NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma","volume":"4","author":"Hamad","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1038\/s41388-023-02783-7","article-title":"Genetically engineered mouse models of head and neck cancers","volume":"42","author":"Tasoulas","year":"2023","journal-title":"Oncogene"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s42003-022-03675-4","article-title":"Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinoma","volume":"5","author":"Shi","year":"2022","journal-title":"Commun. Biol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/1541-7786.MCR-19-0549","article-title":"PIK3CA and p53 Mutations Promote 4NQO-Initated Head and Neck Tumor Progression and Metastasis in Mice","volume":"18","author":"Cai","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajpath.2017.09.013","article-title":"Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell Carcinoma","volume":"188","author":"Krupar","year":"2018","journal-title":"Am. J. Pathol."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Malvi, P., Singh, S.V., and Chaube, B. (2025). Editorial: Metabolic crosstalk between cancer cells and immune cells in the tumor microenvironment: Cellular and molecular insights, and their therapeutic implications. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1751044"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1038\/s41467-024-51450-2","article-title":"Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer","volume":"15","author":"Graham","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Sell\u00e6g, K., Schwienbacher, R., Kranz, M., Aamodt, A.E., Wirsing, A.M., Berge, G., Hadler-Olsen, E., and Magnussen, S.N. (2024). 4-nitroquinoline 1-oxide-induced oral epithelial lesions exhibit time- and stage-dependent changes in the tumor immune microenvironment. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1343839"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.neo.2020.10.003","article-title":"Molecular homology between canine spontaneous oral squamous cell carcinomas and human head-and-neck squamous cell carcinomas reveals disease drivers and therapeutic vulnerabilities","volume":"22","author":"Guscetti","year":"2020","journal-title":"Neoplasia"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1101\/gad.320481.118","article-title":"Autophagy modulates lipid metabolism to maintain metabolic flexibility for Lkb1 -deficient Kras -driven lung tumorigenesis","volume":"33","author":"Bhatt","year":"2019","journal-title":"Genes Dev."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1158\/0008-5472.CAN-23-3594","article-title":"Integrative Multiomics Analyses Identify Molecular Subtypes of Head and Neck Squamous Cell Carcinoma with Distinct Therapeutic Vulnerabilities","volume":"84","author":"Diao","year":"2024","journal-title":"Cancer Res."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Hatipoglu, A., Menon, D., Levy, T., Frias, M.A., and Foster, D.A. (2022). Inhibiting glutamine utilization creates a synthetic lethality for suppression of ATP citrate lyase in KRas-driven cancer cells. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0276579"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Palmieri, M.A., Monti Hughes, A., Trivillin, V.A., Garabalino, M.A., Ramos, P.S., Thorp, S.I., Curotto, P., Pozzi, E.C.C., Nuez Mart\u00ednez, M., and Teixidor, F. (2024). Cobaltabis(Dicarbollide) [o-COSAN]\u2212 for Boron Neutron Capture Therapy of Head and Neck Cancer: Biodistribution and Irradiation Studies in an Experimental Oral Cancer Model. Pharmaceuticals, 17.","DOI":"10.3390\/ph17101367"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Frederick, C.E. (2024). Obtaining informed consent in veterinary clinical trials mini review. Front. Vet. Sci., 11.","DOI":"10.3389\/fvets.2024.1426014"},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Giuliano, A. (2021). Companion Animal Model in Translational Oncology; Feline Oral Squamous Cell Carcinoma and Canine Oral Melanoma. Biology, 11.","DOI":"10.3390\/biology11010054"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"4350783","DOI":"10.1155\/2020\/4350783","article-title":"Knockdown of Matrix Metallopeptidase 9 Inhibits Metastasis of Oral Squamous Cell Carcinoma Cells in a Zebrafish Xenograft Model","volume":"2020","author":"Wen","year":"2020","journal-title":"BioMed Res. Int."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s13577-024-01114-6","article-title":"Zebrafish larvae as a model for studying the impact of oral bacterial vesicles on tumor cell growth and metastasis","volume":"37","author":"Hasnat","year":"2024","journal-title":"Hum. Cell"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Olaiz, N., Monti Hughes, A., Pozzi, E.C.C., Thorp, S., Curotto, P., Trivillin, V.A., Ramos, P.S., Palmieri, M.A., Marshall, G., and Schwint, A.E. (2023). Enhancement in the Therapeutic Efficacy of In Vivo BNCT Mediated by GB-10 with Electroporation in a Model of Oral Cancer. Cells, 12.","DOI":"10.3390\/cells12091241"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"e23553","DOI":"10.1002\/jbt.23553","article-title":"Usnic acid attenuates 7,12-dimethylbenz[a] anthracene (DMBA) induced oral carcinogenesis through inhibiting oxidative stress, inflammation, and cell proliferation in male golden Syrian hamster model","volume":"38","author":"Azhamuthu","year":"2024","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Lo Re, O., Corti, C., Cerrito, L., Cesari, E., Creta, E., De Maio, F., Di Prima, A., Facciuto, V., Ferraro, C., and Huqi, E. (2026). Establishment of Patient-Derived Organoids from Hepatocellular Carcinoma: Preliminary Data on Yield, Histopathological Concordance, and Methodological Challenges. Cells, 15.","DOI":"10.3390\/cells15020125"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"38973","DOI":"10.18632\/oncotarget.9971","article-title":"Correction: Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle","volume":"7","author":"Pretto","year":"2016","journal-title":"Oncotarget"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-pathmechdis-012419-032611","article-title":"Human Organoids: Tools for Understanding Biology and Treating Diseases","volume":"15","author":"Schutgens","year":"2020","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"460","DOI":"10.7150\/thno.87329","article-title":"Differential effect of cancer-associated fibroblast-derived extracellular vesicles on cisplatin resistance in oral squamous cell carcinoma via miR-876-3p","volume":"14","author":"Kang","year":"2024","journal-title":"Theranostics"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s43018-026-01130-5","article-title":"The GENEVA platform models tumor mosaicism to reveal variations of responses to KRAS inhibitors and identify improved drug combinations","volume":"7","author":"Yu","year":"2026","journal-title":"Nat. Cancer"},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Fawaz, A., Ferraresi, A., and Isidoro, C. (2023). Systems Biology in Cancer Diagnosis Integrating Omics Technologies and Artificial Intelligence to Support Physician Decision Making. J. Pers. Med., 13.","DOI":"10.20944\/preprints202310.1262.v1"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-021-03634-9","article-title":"Exploring tissue architecture using spatial transcriptomics","volume":"596","author":"Rao","year":"2021","journal-title":"Nature"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"105480","DOI":"10.1016\/j.jprot.2025.105480","article-title":"Multi-omics reveals miR-181a-5p regulates PPAR-driven lipid metabolism in Oral squamous cell carcinoma: Insights from CRISPR\/Cas9 knockout models","volume":"319","author":"Wang","year":"2025","journal-title":"J. Proteom."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41698-024-00764-x","article-title":"Multi-omics analysis deciphers intercellular communication regulating oxidative stress to promote oral squamous cell carcinoma progression","volume":"8","author":"Zhang","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41368-023-00267-8","article-title":"Spatial transcriptomics reveals that metabolic characteristics define the tumor immunosuppression microenvironment via iCAF transformation in oral squamous cell carcinoma","volume":"16","author":"Liu","year":"2024","journal-title":"Int. J. Oral Sci."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"107918","DOI":"10.1016\/j.oraloncology.2026.107918","article-title":"Spatial transcriptomics and single-cell analysis reveal GSTO2-mediated protective networks in oral squamous cell carcinoma tumor microenvironment","volume":"175","author":"Meng","year":"2026","journal-title":"Oral Oncol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"100432","DOI":"10.1016\/j.slast.2026.100432","article-title":"Integrative Single-Cell and Bulk Transcriptomics Analysis Reveals Cellular Heterogeneity, Immune Microenvironment Dynamics, and Prognostic Signatures in Oral Squamous Cell Carcinoma","volume":"39","author":"Zhang","year":"2026","journal-title":"SLAS Technol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"102024","DOI":"10.1016\/j.xcrm.2025.102024","article-title":"Immune-featured stromal niches associate with response to neoadjuvant immunotherapy in oral squamous cell carcinoma","volume":"6","author":"Liu","year":"2025","journal-title":"Cell Rep. Med."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Nieberle, F., Spoerl, S., Strotzer, Q., Hartmann, R., Erber, R., Spoerl, S., Schuderer, J.G., Himmelsto\u00df, K., Meier, J., and Ettl, T. (2026). TCGA-Informed Spatial Profiling Reveals Peripheral CD147 Expression at the Invasive Tumor Front as a Prognostic Indicator in OSCC. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27052172"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/s41598-025-31899-x","article-title":"Integrated proteomics and metabolomics analysis revealed that macrophage-related signals may be potential biomarkers for oral squamous cell carcinoma","volume":"16","author":"Yang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1038\/s41467-023-40271-4","article-title":"Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response","volume":"14","author":"Arora","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"26255","DOI":"10.1038\/s41598-024-76044-2","article-title":"Revealing molecular mechanisms of early-onset tongue cancer by spatial transcriptomics","volume":"14","author":"Patysheva","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"e71705","DOI":"10.1002\/cam4.71705","article-title":"CBX3:IL1RN Reflects Distinct Cellular States That Defines the Clinical Outcome of Oral Squamous Cell Carcinoma","volume":"15","author":"Tian","year":"2026","journal-title":"Cancer Med."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"9178","DOI":"10.1097\/JS9.0000000000003647","article-title":"A multi-omics pipeline integrating machine learning and spatial-cellular analysis identifies SASH1 as a prognostic biomarker and therapeutic target in head and neck squamous cell carcinoma","volume":"111","author":"Dai","year":"2025","journal-title":"Int. J. Surg."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s13287-025-04599-6","article-title":"Head and neck cancer organoids: A panoramic perspective from basic construction to clinical translation","volume":"16","author":"Meng","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"101483","DOI":"10.1016\/j.tranon.2022.101483","article-title":"A novel 3D pillar\/well array platform using patient-derived head and neck tumor to predict the individual radioresponse","volume":"24","author":"Lee","year":"2022","journal-title":"Transl. Oncol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12935-019-0733-1","article-title":"The effect of 2D and 3D cell cultures on treatment response, EMT profile and stem cell features in head and neck cancer","volume":"19","author":"Melissaridou","year":"2019","journal-title":"Cancer Cell Int."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"e2403114","DOI":"10.1002\/adhm.202403114","article-title":"3D Bioprinted Head and Neck Squamous Cell Carcinoma (HNSCC) Model Using Tunicate Derived Nanocellulose (NC) Bioink","volume":"14","author":"Azhakesan","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"102622","DOI":"10.1016\/j.xcrm.2026.102622","article-title":"A human patient-derived organoid biobank to model tumor heterogeneity and therapeutic vulnerability for oral squamous cell carcinoma","volume":"7","author":"Wang","year":"2026","journal-title":"Cell Rep. Med."},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Ma, H., Liu, C., Li, X., Zuo, L., Li, C., Xu, X., Zhang, S., Ma, X., Yue, E., and Qiao, B. (2025). Lipid metabolites as biomarkers and therapeutic targets in oral squamous cell carcinoma. BMC Oral Health, 25.","DOI":"10.1186\/s12903-025-06700-0"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/cas.14749","article-title":"Similarities and differences in metabolites of tongue cancer cells among two- and three-dimensional cultures and xenografts","volume":"112","author":"Murakami","year":"2021","journal-title":"Cancer Sci."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/onc.2015.220","article-title":"ErbB3 upregulation by the HNSCC 3D microenvironment modulates cell survival and growth","volume":"35","author":"Humtsoe","year":"2016","journal-title":"Oncogene"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2015.08.068","article-title":"Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges","volume":"163","author":"Day","year":"2015","journal-title":"Cell"},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Lee, Y., Lee, M., Shin, Y., Kim, K., and Kim, T. (2025). Spatial Omics in Clinical Research: A Comprehensive Review of Technologies and Guidelines for Applications. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26093949"},{"key":"ref_197","first-page":"3","article-title":"Nanomedicine internalization and penetration: Why should we use spheroids?","volume":"1","author":"Pinto","year":"2022","journal-title":"Sci. Lett."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Lu, H., Zhang, S., Wang, J., and Chen, Q. (2021). A Review on Polymer and Lipid-Based Nanocarriers and Its Application to Nano-Pharmaceutical and Food-Based Systems. Front. Nutr., 8.","DOI":"10.3389\/fnut.2021.783831"},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Sercombe, L., Veerati, T., Moheimani, F., Wu, S.Y., Sood, A.K., and Hua, S. (2015). Advances and Challenges of Liposome Assisted Drug Delivery. Front. Pharmacol., 6.","DOI":"10.3389\/fphar.2015.00286"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/1735-5362.235156","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: Applications, advantages and disadvantages","volume":"13","author":"Ghasemiyeh","year":"2018","journal-title":"Res. Pharm. Sci."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"32572","DOI":"10.1039\/D5RA01788B","article-title":"Polymeric nanomaterials as a drug delivery system for anticancer and antibacterial infections: A review","volume":"15","author":"Harini","year":"2025","journal-title":"RSC Adv."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"19833","DOI":"10.1039\/D0NR04682E","article-title":"Functional blockade of cancer-associated fibroblasts with ultrafine gold nanomaterials causes an unprecedented bystander antitumoral effect","volume":"12","author":"Xia","year":"2020","journal-title":"Nanoscale"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"100869","DOI":"10.1016\/j.coche.2022.100869","article-title":"Inorganic nanoparticles for oral drug delivery: Opportunities, barriers, and future perspectives","volume":"38","author":"Asad","year":"2022","journal-title":"Curr. Opin. Chem. Eng."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Hu, X., Zhang, Y., Ding, T., Liu, J., and Zhao, H. (2020). Multifunctional Gold Nanoparticles: A Novel Nanomaterial for Various Medical Applications and Biological Activities. Front. Bioeng. Biotechnol., 8.","DOI":"10.3389\/fbioe.2020.00990"},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Lee, S.H., and Jun, B.-H. (2019). Silver Nanoparticles: Synthesis and Application for Nanomedicine. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20040865"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.7150\/thno.25220","article-title":"Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics","volume":"8","author":"Xie","year":"2018","journal-title":"Theranostics"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.addr.2019.01.005","article-title":"Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications","volume":"138","author":"Dadfar","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"121757","DOI":"10.1016\/j.biomaterials.2022.121757","article-title":"Ru(II)-modified TiO2 nanoparticles for hypoxia-adaptive photo-immunotherapy of oral squamous cell carcinoma","volume":"289","author":"Zhou","year":"2022","journal-title":"Biomaterials"},{"key":"ref_209","first-page":"209","article-title":"Effects of TiO2 nanoparticles on cytotoxic action of chemotherapeutic drugs against a human oral squamous cell carcinoma cell line","volume":"28","author":"Ando","year":"2014","journal-title":"In Vivo"},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Ziental, D., Czarczynska-Goslinska, B., Mlynarczyk, D.T., Glowacka-Sobotta, A., Stanisz, B., Goslinski, T., and Sobotta, L. (2020). Titanium Dioxide Nanoparticles: Prospects and Applications in Medicine. Nanomaterials, 10.","DOI":"10.20944\/preprints202002.0271.v1"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s12633-019-00229-y","article-title":"Multifaceted Application of Silica Nanoparticles. A Review","volume":"12","author":"Jeelani","year":"2020","journal-title":"Silicon"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.2147\/IJN.S357980","article-title":"Biomedical Applications of Quantum Dots: Overview, Challenges, and Clinical Potential","volume":"17","author":"Abdellatif","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1039\/D4NA00501E","article-title":"A comprehensive review of challenges and advances in exosome-based drug delivery systems","volume":"6","author":"Palakurthi","year":"2024","journal-title":"Nanoscale Adv."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1016\/j.apsb.2022.12.022","article-title":"Plant-derived nanovesicles: Further exploration of biomedical function and application potential","volume":"13","author":"Li","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"20214","DOI":"10.1021\/acsami.0c03022","article-title":"Mild Acid-Responsive \u201cNanoenzyme Capsule\u201d Remodeling of the Tumor Microenvironment to Increase Tumor Penetration","volume":"12","author":"Yao","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12951-024-02433-4","article-title":"Macrophage membrane-camouflaged pH-sensitive nanoparticles for targeted therapy of oral squamous cell carcinoma","volume":"22","author":"Yang","year":"2024","journal-title":"J. NanobioTechnol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"100083","DOI":"10.1016\/j.ntm.2025.100083","article-title":"Nanoparticles for drug delivery: Insight into in vitro and in vivo drug release from nanomedicines","volume":"4","author":"Ewii","year":"2025","journal-title":"Nano TransMed"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/00220345231216110","article-title":"CaCO 3 Nanoparticles Delivering MicroRNA-200c Suppress Oral Squamous Cell Carcinoma","volume":"103","author":"Ding","year":"2024","journal-title":"J. Dent. Res."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.colsurfb.2015.05.014","article-title":"An insight into functionalized calcium based inorganic nanomaterials in biomedicine: Trends and transitions","volume":"133","author":"Sharma","year":"2015","journal-title":"Colloids Surf. B BioInterfaces"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/03639045.2021.1934858","article-title":"Effectual nanotherapy against oral squamous cell carcinoma","volume":"47","author":"Bharadwaj","year":"2021","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1080\/21691401.2020.1843782","article-title":"Correction: Combinatorial therapeutic approach for treatment of oral squamous cell carcinoma","volume":"48","author":"Bharadwaj","year":"2020","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1039\/C9TB02818H","article-title":"Glutathione-sensitive and folate-targeted nanoparticles loaded with paclitaxel to enhance oral squamous cell carcinoma therapy","volume":"8","author":"Fan","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12943-016-0503-9","article-title":"Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients","volume":"15","author":"Ruan","year":"2016","journal-title":"Mol. Cancer"},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Lang, L., Lam, T., Chen, A., Jensen, C., Duncan, L., Kong, F.-C., Kurago, Z.B., Shay, C., and Teng, Y. (2020). Circumventing AKT-Associated Radioresistance in Oral Cancer by Novel Nanoparticle-Encapsulated Capivasertib. Cells, 9.","DOI":"10.3390\/cells9030533"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s12013-014-9849-z","article-title":"Antitumor Effect of TRAIL on Oral Squamous Cell Carcinoma using Magnetic Nanoparticle-Mediated Gene Expression","volume":"69","author":"Miao","year":"2014","journal-title":"Cell Biochem. Biophys."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.7314\/APJCP.2014.15.15.6227","article-title":"Novel DOX-MTX Nanoparticles Improve Oral SCC Clinical Outcome by Down Regulation of Lymph Dissemination Factor VEGF-C Expression in vivo: Oral and IV Modalities","volume":"15","author":"Abbasi","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.7314\/APJCP.2014.15.24.10705","article-title":"Oral and IV Dosages of Doxorubicin-Methotrexate loaded-Nanoparticles Inhibit Progression of Oral Cancer by Down-Regulation of Matrix Methaloproteinase 2 Expression in Vivo","volume":"15","author":"Abbasi","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s11658-022-00407-8","article-title":"MF-094 nanodelivery inhibits oral squamous cell carcinoma by targeting USP30","volume":"27","author":"Zhang","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"101203","DOI":"10.1016\/j.jpha.2025.101203","article-title":"pH-responsive biomimetic zeolitic imidazolate framework-based nanoparticles for co-delivery of cetuximab and siRNA in synergistic therapy of laryngeal squamous cell carcinoma","volume":"15","author":"Wang","year":"2025","journal-title":"J. Pharm. Anal."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"109214","DOI":"10.1016\/j.porgcoat.2025.109214","article-title":"Stability and activity of the polydopamine coating over time","volume":"204","author":"Moraczewski","year":"2025","journal-title":"Prog. Org. Coat."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2147\/IJN.S225197","article-title":"Incorporation of ROS-Responsive Substance P-Loaded Zeolite Imidazolate Framework-8 Nanoparticles into a Ca2+-Cross-Linked Alginate\/Pectin Hydrogel for Wound Dressing Applications","volume":"15","author":"Zhu","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1186\/s12951-025-03577-7","article-title":"Delivery of an ERK inhibitor using bioactive lipid nanoparticles reduces angiogenesis and prevents oral squamous cell carcinoma development","volume":"23","author":"Huang","year":"2025","journal-title":"J. NanobioTechnol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"103114","DOI":"10.1016\/j.mtbio.2026.103114","article-title":"Antiangiogenic DPPA-nanoparticles combined with an immune checkpoint inhibitor for the treatment of unresectable hepatocellular carcinoma","volume":"38","author":"Huang","year":"2026","journal-title":"Mater. Today Bio"},{"key":"ref_234","doi-asserted-by":"crossref","unstructured":"Chen, L., Feng, C., Shi, Z., Wang, J., Wang, T., Wang, Y., Lin, L., and Wu, Y. (2025). PLGA-based herb Toosendanin delivery system for efficient therapy of oral squamous cell carcinoma. BMC Complement. Med. Ther., 25.","DOI":"10.1186\/s12906-025-04957-0"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.nano.2018.01.007","article-title":"Metallic gold and bioactive quinacrine hybrid nanoparticles inhibit oral cancer stem cell and angiogenesis by deregulating inflammatory cytokines in p53 dependent manner","volume":"14","author":"Satapathy","year":"2018","journal-title":"NanoMed. NanoTechnol. Biol. Med."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1021\/acs.molpharmaceut.5b00461","article-title":"Enhancement of Cytotoxicity and Inhibition of Angiogenesis in Oral Cancer Stem Cells by a Hybrid Nanoparticle of Bioactive Quinacrine and Silver: Implication of Base Excision Repair Cascade","volume":"12","author":"Satapathy","year":"2015","journal-title":"Mol. Pharm."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1021\/acs.molpharmaceut.0c00197","article-title":"Quinacrine Based Gold Hybrid Nanoparticles Caused Apoptosis through Modulating Replication Fork in Oral Cancer Stem Cells","volume":"17","author":"Hembram","year":"2020","journal-title":"Mol. Pharm."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"102502","DOI":"10.1016\/j.nano.2021.102502","article-title":"NIR irradiation enhances the apoptotic potentiality of quinacrine-gold hybrid nanoparticles by modulation of HSP-70 in oral cancer stem cells","volume":"40","author":"Dash","year":"2022","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1021\/acs.molpharmaceut.9b00242","article-title":"Comparative and Mechanistic Study on the Anticancer Activity of Quinacrine-Based Silver and Gold Hybrid Nanoparticles in Head and Neck Cancer","volume":"16","author":"Hembram","year":"2019","journal-title":"Mol. Pharm."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"112253","DOI":"10.1016\/j.cellsig.2025.112253","article-title":"Targeting LINC02613 to inhibit oral squamous cell carcinoma metastasis and progression via the rehabilitation of LCP1 ubiquitination","volume":"138","author":"Jiang","year":"2026","journal-title":"Cell Signal."},{"key":"ref_242","doi-asserted-by":"crossref","unstructured":"Elmowafy, M., Shalaby, K., Elkomy, M.H., Alsaidan, O.A., Gomaa, H.A.M., Abdelgawad, M.A., and Mostafa, E.M. (2023). Polymeric Nanoparticles for Delivery of Natural Bioactive Agents: Recent Advances and Challenges. Polymers, 15.","DOI":"10.3390\/polym15051123"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"e202307706","DOI":"10.1002\/anie.202307706","article-title":"Sodium Bicarbonate Nanoparticles for Amplified Cancer Immunotherapy by Inducing Pyroptosis and Regulating Lactic Acid Metabolism","volume":"62","author":"Ding","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40005-023-00649-4","article-title":"Applying polyvinyl alcohol to the preparation of various nanoparticles","volume":"54","author":"Song","year":"2024","journal-title":"J. Pharm. Investig."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.trsl.2024.03.004","article-title":"Reversal of cisplatin resistance in oral squamous cell carcinoma by piperlongumine loaded smart nanoparticles through inhibition of Hippo-YAP signaling pathway","volume":"268","author":"Sa","year":"2024","journal-title":"Transl. Res."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/pat.5514","article-title":"Preparation and mechanical properties of poly(\u03b3-benzyll-glutamate) modified nano-silica reinforced polyurea composites","volume":"33","author":"Li","year":"2022","journal-title":"Polym. Adv. Technol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2217\/17435889.3.6.813","article-title":"PEG-PBLG Nanoparticle-Mediated HSV-TK\/GCV Gene Therapy for Oral Squamous Cell Carcinoma","volume":"3","author":"Yu","year":"2008","journal-title":"Nanomedicine"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1016\/j.vaccine.2011.05.072","article-title":"Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators","volume":"29","author":"Camacho","year":"2011","journal-title":"Vaccine"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1186\/s12951-026-04469-0","article-title":"Biomimetic PD-1 macrophage nanoplatform for Cip2a silencing and immune activation in oral squamous cell carcinoma","volume":"24","author":"Zhang","year":"2026","journal-title":"J. NanobioTechnol."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13046-023-02618-z","article-title":"Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling","volume":"42","author":"Huang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"124528","DOI":"10.1016\/j.ijbiomac.2023.124528","article-title":"Fucoidan\/hyaluronic acid cross-linked zein nanoparticles loaded with fisetin as a novel targeted nanotherapy for oral cancer","volume":"241","author":"Moustafa","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"153386","DOI":"10.1016\/j.phymed.2020.153386","article-title":"Genistein nanoformulation promotes selective apoptosis in oral squamous cell carcinoma through repression of 3PK-EZH2 signalling pathway","volume":"80","author":"Dev","year":"2021","journal-title":"Phytomedicine"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.5114\/aoms\/189535","article-title":"Combretastatin A4 phosphate encapsulated in hyaluronic acid nanoparticles is highly cytotoxic to oral squamous cell carcinoma","volume":"20","author":"Sun","year":"2024","journal-title":"Arch. Med. Sci."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12951-021-01125-7","article-title":"Gelatinase-sensitive nanoparticles loaded with photosensitizer and STAT3 inhibitor for cancer photothermal therapy and immunotherapy","volume":"19","author":"Bu","year":"2021","journal-title":"J. NanobioTechnol."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"9638","DOI":"10.1021\/acsnano.5b04520","article-title":"Self-Assembling Monomeric Nucleoside Molecular Nanoparticles Loaded with 5-FU Enhancing Therapeutic Efficacy against Oral Cancer","volume":"9","author":"Zhao","year":"2015","journal-title":"ACS Nano"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jcis.2021.05.126","article-title":"Modification of Metal-Organic Framework Nanoparticles Using Dental Pulp Mesenchymal Stem Cell Membranes to Target Oral Squamous Cell Carcinoma","volume":"601","author":"Zhou","year":"2021","journal-title":"J. Colloid Interface Sci."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"123667","DOI":"10.1016\/j.ijpharm.2023.123667","article-title":"Near-infrared-responsive GE11-CuS@Gal nanoparticles as an intelligent drug release system for targeting therapy against oral squamous cell carcinoma","volume":"649","author":"Lan","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"8423","DOI":"10.1021\/acsnano.8b03900","article-title":"Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors","volume":"12","author":"Dai","year":"2018","journal-title":"ACS Nano"},{"key":"ref_259","doi-asserted-by":"crossref","unstructured":"Choi, J.-H., Gu, H.-J., Park, K.-H., Hwang, D.-S., and Kim, G.-C. (2022). Anti-Cancer Activity of the Combinational Treatment of Noozone Cold Plasma with p-FAK Antibody-Conjugated Gold Nanoparticles in OSCC Xenograft Mice. Biomedicines, 10.","DOI":"10.3390\/biomedicines10092259"},{"key":"ref_260","doi-asserted-by":"crossref","unstructured":"Gusti-Ngurah-Putu, E.-P., Huang, L., and Hsu, Y.-C. (2019). Effective Combined Photodynamic Therapy with Lipid Platinum Chloride Nanoparticles Therapies of Oral Squamous Carcinoma Tumor Inhibition. J. Clin. Med., 8.","DOI":"10.3390\/jcm8122112"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1039\/C9BM01192G","article-title":"A near infrared light-triggered human serum albumin drug delivery system with coordination bonding of indocyanine green and cisplatin for targeting photochemistry therapy against oral squamous cell cancer","volume":"7","author":"Wang","year":"2019","journal-title":"Biomater. Sci."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"105173","DOI":"10.1016\/j.oraloncology.2020.105173","article-title":"Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial","volume":"115","author":"Adkins","year":"2021","journal-title":"Oral Oncol."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"10667","DOI":"10.2147\/IJN.S528763","article-title":"Prussian Blue Nanoparticle-Induced Alteration of the Polarization State of Tumor-Associated Macrophages as a Substantial Antitumor Mechanism Against Oral Squamous Cell Carcinoma (OSCC)","volume":"20","author":"Zhang","year":"2025","journal-title":"Int. J. NanoMed."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"113713","DOI":"10.1016\/j.colsurfb.2023.113713","article-title":"Tumor microenvironment-activatable nanocatalysts with chemodynamic therapy and enhanced autophagy for specific treatment of oral squamous cell carcinoma","volume":"236","author":"Xu","year":"2024","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/00220345241238154","article-title":"An Acid-Responsive Iron-Based Nanocomposite for OSCC Treatment","volume":"103","author":"Zhao","year":"2024","journal-title":"J. Dent. Res."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"174400","DOI":"10.1016\/j.ejphar.2021.174400","article-title":"Quercetin and piperine enriched nanostructured lipid carriers (NLCs) to improve apoptosis in oral squamous cellular carcinoma (FaDu cells) with improved biodistribution profile","volume":"909","author":"Chaudhari","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"104337","DOI":"10.1016\/j.pdpdt.2024.104337","article-title":"Peptide-mediated targeting of Quantum Dots in a 3D model of head and neck cancer","volume":"49","author":"Dirheimer","year":"2024","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"116011","DOI":"10.1016\/j.biopha.2023.116011","article-title":"Near-infrared-II Ag2S quantum dot probes targeting podoplanin enhance immunotherapy in oral squamous cell carcinoma","volume":"170","author":"Xiong","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"e70041","DOI":"10.1111\/cpr.70041","article-title":"Synergistical Induction of Apoptosis via Cold Atmospheric Plasma and Nanohydroxyapatite for Selective Inhibition of Oral Squamous Cell Carcinoma in Tumour Microenvironment","volume":"58","author":"Qi","year":"2025","journal-title":"Cell Prolif."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jconrel.2024.03.014","article-title":"Supramolecular nanodrug targeting CDK4\/6 overcomes BAG1 mediated cisplatin resistance in oral squamous cell carcinoma","volume":"368","author":"Zhao","year":"2024","journal-title":"J. Control. Release"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12951-026-04193-9","article-title":"Natural panax notoginseng-derived nanovesicles trigger multiple cell death mechanisms and reprogram chemokine signaling to impede oral squamous cell carcinoma progression","volume":"24","author":"Chen","year":"2026","journal-title":"J. NanobioTechnol."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12951-021-00995-1","article-title":"Bitter melon derived extracellular vesicles enhance the therapeutic effects and reduce the drug resistance of 5-fluorouracil on oral squamous cell carcinoma","volume":"19","author":"Yang","year":"2021","journal-title":"J. NanobioTechnol."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"11265","DOI":"10.1039\/D3TB02046K","article-title":"A biomimetic phototherapeutic nanoagent based on bacterial double-layered membrane vesicles for comprehensive treatment of oral squamous cell carcinoma","volume":"11","author":"Chen","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13287-022-02764-9","article-title":"Exosomes derived from stem cells of human deciduous exfoliated teeth inhibit angiogenesis in vivo and in vitro via the transfer of miR-100-5p and miR-1246","volume":"13","author":"Liu","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"ref_275","doi-asserted-by":"crossref","unstructured":"Li, M., Yin, S., Xu, A., Kang, L., Ma, Z., Liu, F., Yang, T., Sun, P., and Tang, Y. (2023). Synergistic Phototherapy-Molecular Targeted Therapy Combined with Tumor Exosome Nanoparticles for Oral Squamous Cell Carcinoma Treatment. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16010033"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"124668","DOI":"10.1016\/j.carbpol.2025.124668","article-title":"Carboxymethyl chitosan-based injectable hydrogel immobilizing single-atom nanozymes for localized ROS amplification and ferroptosis-enhanced postoperative oral cancer therapy","volume":"373","author":"Qi","year":"2026","journal-title":"Carbohydr. Polym."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"140679","DOI":"10.1016\/j.ijbiomac.2025.140679","article-title":"Targeted therapeutic strategy for oral squamous carcinoma using celecoxib-loaded GABA\/wheat gluten-alginate nanocarrier hydrogel with glutathione down-regulation and enhanced CCND2-mediated apoptosis","volume":"303","author":"Li","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/10717544.2022.2155269","article-title":"Utilization of a nanostructured lipid carrier encapsulating pitavastatin\u2013 Pinus densiflora oil for enhancing cytotoxicity against the gingival carcinoma HGF-1 cell line","volume":"30","author":"Felimban","year":"2023","journal-title":"Drug Deliv."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"2402895","DOI":"10.1002\/adhm.202402895","article-title":"Programmable DNA Hydrogels with Zinc Oxide Nanoparticles and Cisplatin for Diagnosis and Treatment of Oral Squamous Cell Carcinoma","volume":"14","author":"Zhao","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"ref_280","doi-asserted-by":"crossref","unstructured":"Song, S., Sun, X., Wang, Y., Wang, M., Shi, Z., Sun, D., Li, D., Chen, J., and Wang, C. (2025). Sodium alginate hydrogel loaded with upconversion nanoparticles and magnesium ions enhances bone regeneration and photodynamic tumor therapy. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1543678"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1039\/D1LC00192B","article-title":"Quantifying nanotherapeutic penetration using a hydrogel-based microsystem as a new 3D in vitro platform","volume":"21","author":"Goodarzi","year":"2021","journal-title":"Lab Chip"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/nnm.16.5","article-title":"The Effect of Nanoparticle Size on In Vivo Pharmacokinetics and Cellular Interaction","volume":"11","author":"Hoshyar","year":"2016","journal-title":"Nanomedicine"},{"key":"ref_283","doi-asserted-by":"crossref","unstructured":"Adkins, D., Ley, J.C., Auberle, C., Knapp, B., Zaretsky, J., Liu, J., and Oppelt, P. (2026). Nanoparticle Albumin-Bound Paclitaxel and Nivolumab for PD-1 Inhibitor-Refractory Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma. Cancer Med., 15.","DOI":"10.1002\/cam4.71533"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/cam4.382","article-title":"Nab-paclitaxel-based compared to docetaxel-based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neck","volume":"4","author":"Schell","year":"2015","journal-title":"Cancer Med."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12032-021-01479-w","article-title":"nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: A multicenter, non-randomized phase 2 trial","volume":"38","author":"Oppelt","year":"2021","journal-title":"Med. Oncol."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/s41416-022-01941-0","article-title":"Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma","volume":"127","author":"Rosenberg","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.oraloncology.2017.04.018","article-title":"A phase II trial of induction NAB-paclitaxel and cisplatin followed by concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma","volume":"70","author":"Ke","year":"2017","journal-title":"Oral Oncol."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.jvir.2007.06.009","article-title":"Feasibility and Efficacy of Percutaneous Transcatheter Intraarterial Chemotherapy with Paclitaxel in Albumin Nanoparticles for Advanced Squamous-Cell Carcinoma of the Oral Cavity, Oropharynx, and Hypopharynx","volume":"18","author":"Damascelli","year":"2007","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1002\/1097-0142(20011115)92:10<2592::AID-CNCR1612>3.0.CO;2-4","article-title":"Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI-007)","volume":"92","author":"Damascelli","year":"2001","journal-title":"Cancer"},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejca.2021.01.007","article-title":"Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx","volume":"146","author":"Hoffmann","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1001\/jamaoto.2025.4939","article-title":"Intratumoral Radioenhancer Nanoparticle NBTXR3 Followed by Radiotherapy in Head and Neck Cancer","volume":"152","author":"Liem","year":"2026","journal-title":"JAMA Otolaryngol. Neck Surg."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S1470-2045(12)70476-X","article-title":"Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: A phase 1 dose-escalation study","volume":"13","author":"Mamot","year":"2012","journal-title":"Lancet Oncol."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1158\/1078-0432.CCR-17-1114","article-title":"Phase Ib\/II Trial of NC-6004 (Nanoparticle Cisplatin) Plus Gemcitabine in Patients with Advanced Solid Tumors","volume":"24","author":"Subbiah","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_294","first-page":"3961","article-title":"First safety and response results of a randomized phase III study with liposomal platin in the treatment of advanced squamous cell carcinoma of the head and neck (SCCHN)","volume":"28","author":"Jehn","year":"2008","journal-title":"Anticancer Res."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1023\/A:1016201732368","article-title":"A Phase I Study of SPI-077 (Stealth\u00ae Liposomal Cisplatin) Concurrent with Radiation Therapy for Locally Advanced Head and Neck Cancer","volume":"20","author":"Rosenthal","year":"2002","journal-title":"Investig. New Drugs"},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1038\/s41467-022-31859-3","article-title":"A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer","volume":"13","author":"Goldberg","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"31602","DOI":"10.1038\/s41598-025-16848-y","article-title":"Distinct safety profiles of albumin-bound nab-paclitaxel and paclitaxel in pancreatic cancer focusing on hematologic and hepatobiliary risks","volume":"15","author":"Qin","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_298","first-page":"e39872","article-title":"Toxicity of Nab-Paclitaxel Compared to Paclitaxel in a Tertiary Hospital in Jeddah, Saudi Arabia: A Retrospective Cohort Study","volume":"15","author":"Alhebshi","year":"2023","journal-title":"Cureus"},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/s12964-024-01884-4","article-title":"Tumor-microenvironment-on-a-chip: The construction and application","volume":"22","author":"Xu","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1021\/acs.molpharmaceut.5c01062","article-title":"3D Bioprinting and Artificial Intelligence for Tumor Microenvironment Modeling: A Scoping Review of Models, Methods, and Integration Pathways","volume":"22","author":"Piotrowska","year":"2025","journal-title":"Mol. Pharm."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"102379","DOI":"10.1016\/j.stemcr.2024.11.009","article-title":"Engineering the 3D structure of organoids","volume":"20","author":"Moss","year":"2025","journal-title":"Stem Cell Rep."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/8\/995\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T09:16:09Z","timestamp":1786526169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/8\/995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":301,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["pharmaceutics18080995"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics18080995","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]}}}